Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer

BACKGROUND: This study aimed to evaluate the feasibility, safety, and efficacy of postoperative adjuvant chemotherapy with docetaxel/cisplatin/S-1 (DCS) following S-1 therapy in patients with stage III gastric cancer after curative gastrectomy. METHODS: Patients with stage III gastric cancer who und...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirahara, Noriyuki, Matsubara, Takeshi, Kaji, Shunsuke, Yamamoto, Tetsu, Hyakudomi, Ryoji, Takai, Kiyoe, Ishitobi, Kazunari, Uchida, Yuki, Tajima, Yoshitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485556/
https://www.ncbi.nlm.nih.gov/pubmed/34598694
http://dx.doi.org/10.1186/s12885-021-08795-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485556/
https://www.ncbi.nlm.nih.gov/pubmed/34598694
http://dx.doi.org/10.1186/s12885-021-08795-4

Ejemplares similares